61. Ribavirin For Respiratory Syncytial Virus Infection Of The Lower Respiratory Tra All rights reserved. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract (Cochrane Review). Randolph AG, Wang EEL. ABSTRACT. http://www.update-software.com/abstracts/AB000181.htm

From The Cochrane Library, Issue 2, 2004 Ribavirin for respiratory syncytial virus infection of the lower respiratory tract (Cochrane Review) Randolph AG, Wang EEL ABSTRACT Order full review View and/or submit comments What's new in this issue Search abstracts ... Browse by Review Group A substantive amendment to this systematic review was last made on 11 January 2000. Cochrane reviews are regularly checked and updated if necessary. Background: Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infection in infants leading to 100,000 hospitalizations annually. Ribavirin is approved for treatment of these infections, but its use is controversial because of questions on its efficacy, concerns about occupational exposure and its high cost. Objectives: Respiratory syncytial virus (RSV) is a common cause of pneumonia in infants. Ribavirin is the only antiviral therapy available against RSV. The objective of this review was to assess the effects of aerosolized ribavirin for infants with RSV lower respiratory tract infection. Search strategy: We searched MEDLINE from 1975 to 1999, we scanned reference lists of articles, and we contacted experts in the field.

62. Immunoglobulin For Preventing Respiratory Syncytial Virus Infection (Cochrane Re All rights reserved. Immunoglobulin for preventing respiratory syncytial virus infection (Cochrane Review). Wang EEL, Tang NK. ABSTRACT. http://www.update-software.com/abstracts/AB001725.htm

From The Cochrane Library, Issue 2, 2004 Immunoglobulin for preventing respiratory syncytial virus infection (Cochrane Review) Wang EEL, Tang NK ABSTRACT Order full review View and/or submit comments What's new in this issue Search abstracts ... Browse by Review Group A substantive amendment to this systematic review was last made on 10 March 1999. Cochrane reviews are regularly checked and updated if necessary. Background: Respiratory Syncytial virus, the most important cause of lower respiratory tract infections in infants and young children in industrialized countries, is associated with increased morbidity in premature infants with or without bronchopulmonary dysplasia as well as those with congenital heart disease. Because of observations that lower rates of disease occur immediately after birth, presumably due to vertical transmission of maternal antibody, and animal studies where protection from pneumonia was observed through administration of immune globulin, the efficacy of passive prophylaxis in premature infants has been studied. Objectives: This meta-analysis was performed to assess the effects of polyclonal respiratory syncytial virus hyperimmune globulin or monoclonal antibody in preventing RSV hospitalization, receipt of intensive care, mechanical ventilation, and mortality in those with underlying prematurity, bronchopulmonary dysplasia, or congenital heart disease.

63. BioMed Central | Full Text | Respiratory Syncytial Virus And TNFalpha Induction respiratory syncytial virus and TNFalpha induction of chemokine gene expression involves differential activation of Rel A and NFkappaB1 Laura R Carpenter http://www.biomedcentral.com/1471-2334/2/5

home journals A-Z journals by subject advanced search ... Volume 2 Viewing options Abstract Full text PDF Pre-publication history Other links: E-mail to a friend Download references Post a comment PubMed record ... ISI Web of Science Search PubMed For Carpenter LR Moy JN Roebuck KA Key E-mail Corresponding author Research article Respiratory syncytial virus and TNFalpha induction of chemokine gene expression involves differential activation of Rel A and NF-kappaB1 Laura R Carpenter James N Moy and Kenneth A Roebuck Department of Immunology/Microbiology, Rush-Presbyterian-St. Luke's Medical Center Chicago, IL 60612 BMC Infectious Diseases The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2334/2/5 Received Accepted Published Outline Abstract Abstract Background Materials and methods Results ... Pre-publication history Background Respiratory syncytial virus (RSV) infection of airway epithelial cells stimulates the expression and secretion of a variety of cytokines including the chemotactic cytokines interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), and RANTES (regulated upon activation, normal T cell expressed and secreted). Chemokines are important chemoattractants for the recruitment of distinct sets of leukocytes to airway sites of inflammation. Results We have shown previously that chemokine expression is regulated in airway epithelial cells (A549) in a stimulus-specific manner in part through the redox-responsive transcription factors AP-1 and NF-

64. Entrez PubMed Click here to read respiratory syncytial virus infection in adults. Falsey AR, Walsh EE. Rochester General Hospital and University http://www.biomedcentral.com/pubmed/10885982

Entrez PubMed Nucleotide Protein ... Books Search PubMed Protein Nucleotide Structure Genome Books CancerChromosomes 3D Domains Domains Gene GEO GEO DataSets HomoloGene Journals MeSH NCBI Web Site OMIM PMC PopSet SNP Taxonomy UniGene UniSTS for Limits Preview/Index History Clipboard ... Text Version Entrez PubMed Overview FAQ Tutorial New/Noteworthy ... E-Utilities PubMed Services Journals Database MeSH Database Single Citation Matcher Batch Citation Matcher ... Cubby Related Resources Order Documents NLM Gateway TOXNET Consumer Health ... PubMed Central Summary Brief Abstract Citation ASN.1 MEDLINE XML UI List LinkOut Related Articles Cited in Books CancerChrom Links Domain Links 3D Domain Links GEO DataSet Links Gene Links Genome Links GEO Links HomoloGene Links Nucleotide Links OMIM Links PMC Links Cited in PMC PopSet Links Protein Links SNP Links Structure Links UniSTS Links Show: Sort Author Journal Pub Date Text File Clipboard E-mail Order Clin Microbiol Rev. 2000 Jul;13(3):371-84. Related Articles, Links Respiratory syncytial virus infection in adults. Falsey AR, Walsh EE. Rochester General Hospital and University of Rochester School of Medicine and Dentistry, Rochester, New York 14621, USA. ann.falsey@viahealth.org Publication Types: Review Review, Tutorial

65. NEJM -- Respiratory Syncytial Virus And Parainfluenza Virus Review Article from The New England Journal of Medicine respiratory syncytial virus and Parainfluenza Virus. respiratory syncytial virus. http://content.nejm.org/cgi/content/short/344/25/1917

HOME SEARCH CURRENT ISSUE PAST ISSUES ... HELP Please sign in for full text and personal services Previous Volume 344:1917-1928 June 21, 2001 Number 25 Next Respiratory Syncytial Virus and Parainfluenza Virus Caroline Breese Hall, M.D. Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings. Full Text PDF Add to Personal Archive Add to Citation Manager ... Chapters at Harrison's Respiratory syncytial virus (RSV), originally recovered from a colony of chimpanzees with coryza and designated chimpanzee coryza agent, and human parainfluenza virus types 1, 2, 3, and 4 have been known primarily as respiratory pathogens in young children. They are now recognized as important pathogens in adults as well. Adults infected with these viruses tend to have more variable and less distinctive clinical findings than children, and the viral cause of the infection is often unsuspected. The consistency of the annual outbreaks of these agents and the frequency of reinfection suggest that they impose a considerable, but Full Text of this Article Classification and Structure Epidemiologic Features Pathogenesis Effect of Disease in Children and Adults Infections in Immunocompromised Patients Reinfections in Previously Healthy Persons Immunity Diagnosis Prospects for Immunization Prophylaxis with Immune Globulin Therapy Conclusions References This article has been cited by other articles: Iwane, M. K., Edwards, K. M., Szilagyi, P. G., Walker, F. J., Griffin, M. R., Weinberg, G. A., Coulen, C., Poehling, K. A., Shone, L. P., Balter, S., Hall, C. B., Erdman, D. D., Wooten, K., Schwartz, B., for the New Vaccine Surveillance Network, (2004). Population-Based Surveillance for Hospitalizations Associated With Respiratory Syncytial Virus, Influenza Virus, and Parainfluenza Viruses Among Young Children.

66. Entrez PubMed Click here to read respiratory syncytial virus infection. respiratory syncytial virus Infections*/immunology; respiratory syncytial virus Infections*/therapy; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1

67. Entrez PubMed Click here to read respiratory syncytial virus and parainfluenza virus. Hall CB. University of Rochester School of Medicine and Dentistry, NY, USA. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1

68. Respiratory Syncytial Virus (RSV) From Newborn Infant Nursing Reviews. respiratory syncytial virus (RSV) Overview, Treatment, and Prevention Strategies. Posted 04/13/2004. Mark J. Polak, MD. http://www.medscape.com/viewarticle/472399

69. Update: Respiratory Syncytial Virus Activity -- United States, 1997-98 Season Update respiratory syncytial virus Activity United States, 199798 Season. Appendix N prospects for immunizing against respiratory syncytial virus. http://wonder.cdc.gov/wonder/prevguid/m0050267/m0050267.asp

Warning: This site is being maintained for historical purposes, but has had no new entries since October 1998. To find more recent articles, please visit the following: CDC Recommends at http://www.phppo.cdc.gov/CDCrecommends/AdvSearchV.asp MMWR at http://www.cdc.gov/mmwr/mmwrsrch.htm CDC Web Search at http://www.cdc.gov/search.htm Update: Respiratory Syncytial Virus Activity United States, 1997-98 Season MMWR 46(49);1163-1165 Publication date: 12/12/1997 Table of Contents Article Editorial Note References POINT OF CONTACT FOR THIS DOCUMENT: Figures Percentage of specimens testing positive for ... Article Respiratory syncytial virus (RSV), a common cause of winter outbreaks of acute respiratory disease, results in an estimated 90,000 hospitalizations and 4500 deaths each year from lower respiratory tract disease among infants and young children in the United States (1). Outbreaks occur annually throughout the country (2,3). RSV activity in the United States is monitored by the National Respiratory and Enteric Virus Surveillance System (NREVSS), a voluntary, laboratory-based system. This report summarizes trends in RSV reported by NREVSS for July 1992-June 1997 and presents provisional surveillance results for July-November 1997. These data indicate onset of widespread RSV activity for the 1997-98 season. Since July 1992, a total of 100 clinical and public health laboratories in 47 states have participated in NREVSS and have reported weekly to CDC the number of specimens tested for RSV by the antigen-detection and virus-isolation methods and the number of positive results. RSV activity is considered by NREVSS to have become widespread during the first of 2 consecutive weeks during which at least half of participating laboratories report any RSV detections. This definition generally indicates a mean percentage of specimens positive by antigen detection in excess of 10%.

70. Prevention Guidelines Titles Prevention Guidelines. Topic respiratory syncytial virus. Update respiratory syncytial virus Activity United States, 199798 Season; 19971212. http://wonder.cdc.gov/wonder/prevguid/tp_01600.html

Warning: This site is being maintained for historical purposes, but has had no new entries since October 1998. To find more recent articles, please visit the following: CDC Recommends at http://www.phppo.cdc.gov/CDCrecommends/AdvSearchV.asp MMWR at http://www.cdc.gov/mmwr/mmwrsrch.htm CDC Web Search at http://www.cdc.gov/search.htm Prevention Guidelines Topic: Respiratory Syncytial Virus (Please note that the documents listed below are sorted by date.) Update: Respiratory Syncytial Virus Activity United States, 1997-98 Season Guidelines for Prevention of Nosocomial Pneumonia Home Frequently Asked Questions ... Contact Us This page last reviewed: Wednesday, June 25, 2003 Department of Health and Human Services Centers for Disease Control and Prevention Epidemiology Program Office Division of Public Health Surveillance and Informatics

71. Respiratory Syncytial Virus (RSV) Drugs Lawsuit Overview - Find Trial Lawyers An respiratory syncytial virus (RSV) Drugs Overview respiratory syncytial virus or RSV Drugs Overview - Find Trial Lawyers and Attorneys with Experience in http://www.injuryboard.com/view.cfm/Topic=426

June 2, 2004 There were nearly 96,000 vacant nursing positions at nursing homes across the United States in 2002. Vioxx / Rofecoxib Tractor-Trailer Accidents Serzone / Nefazodone Hydrochloride Tort Reform ... Drugs Respiratory Syncytial Virus or RSV Drugs: Overview If you or a family member has been injured, contact a personal injury attorney today. Just fill out InjuryBoard.com's on-line questionnaire and have a personal injury lawyer review your potential personal injury claim - free of charge. Ask an Attorney Respiratory Syncytial Virus (RSV) is a contagious infection that is usually mild in adults and older children, but can be extremely serious in infants, the elderly, and those with compromised immune systems . Over 120,000 infants and young children are hospitalized each year with RSV. RSV affects the lungs and may lead to pneumonia and other lung diseases Click below to learn more about some specific drugs used to treat or prevent RSV. Would you like to use this material on your law firm web site?

72. Respiratory Syncytial Virus Antigens (immunofluorescence) Detection of respiratory syncytial virus antigens in cells from nasopharyngeal secretions. Indirect immunofluorescence M. Battaglia, L. Balducci. http://pages2.inrete.it/mbiomed/rsvif.htm

PREVIOUS Home Photomicrography Gallery NEXT Detection of respiratory syncytial virus antigens in cells from nasopharyngeal secretions. Indirect immunofluorescence [M. Battaglia, L. Balducci. 1980 - Rapid diagnosis of respiratory syncytial virus infections by immunofluorescence on cell smears from nasopharyngeal secretions. Bollettino dell'Istituto Sieroterapico Milanese

73. AllRefer Health - Respiratory Syncytial Virus (RSV) (RSV) respiratory syncytial virus (RSV) (RSV) information center covers causes, prevention, symptoms, diagnosis, treatment, incidence, risk factors, signs, tests http://health.allrefer.com/health/respiratory-syncytial-virus-rsv-info.html

AllRefer Channels :: Yellow Pages Reference Health Home ... Contact Us Quick Jump ADD/ADHD Allergies Alzheimer's Disease Arthritis Asthma Back Pain Breast Cancer Cancer Colon Cancer Depression Diabetes Gallbladder Disease Heart Attack Hepatitis High Cholesterol HIV/AIDS Hypertension Lung Cancer Menopause Migraines/Headaches Osteoporosis Pneumonia Prostate Cancer SARS Stroke Urinary Tract Infection 1600+ More Conditions Alternative Medicine Health News Symptoms Guide Special Topics ... Medical Encyclopedia You are here : AllRefer.com Health Respiratory Syncytial Virus (RSV) Respiratory Syncytial Virus (RSV) Definition Prevention Treatment Expectations or Prognosis ... Go To Main Page Alternate Names : RSV Definition Respiratory syncytial virus (RSV) is a very common virus that causes mild cold-like symptoms in adults and older healthy children. It can cause serious respiratory infections in young babies, especially those born prematurely, who have heart or lung disease, or who are immunocompromised. Bronchiolitis Gianotti-Crosti Syndrome on the Leg RSV is the most common respiratory pathogen in infants and young children. It has infected nearly all infants by the age of two years. Seasonal outbreaks of

74. Child Health Library - Infectious Diseases - Respiratory Syncytial Virus Information regarding respiratory syncytial virus and the complications it causes in babies from the Child Health Library of Children s Hospital of Pittsburgh. http://www.chp.edu/greystone/infectious/rsv.php

About Parents Professionals Library ... Research Select Another Subject Adolescent Medicine Arthritis Burns Cardiovascular Disorders Craniofacial Anomalies Dermatology Eye Care Growth and Development High-Risk Newborn High-Risk Pregnancy Infectious Diseases Medical Genetics Mental Health Neurological Disorders Normal Newborn Oncology Orthopaedics Respiratory Disorders Surgery Terminally Ill, Care of Transplantation Urology About Pittsburgh Directions and Parking Departments and Services Find a Doctor ... Online Resources Respiratory Syncytial Virus (RSV) What is respiratory syncytial virus (RSV)? RSV is the most common cause of bronchiolitis (inflammation of the lower airways) and pneumonia in babies. It is an illness that often occurs in yearly outbreaks in communities and in newborn intensive care units (NICUs). In the United States, RSV is more common in winter and spring months. What causes respiratory syncytial virus (RSV)?

75. PRESS RELEASE: Respiratory Syncytial Virus (RSV) Is The Leading Cause Of Viral D Delivered by PRWEB Free Press Release Service) Research and Markets have announced the addition of the ‘respiratory syncytial virus Can Antivirals Make http://www.prweb.com/releases/2004/4/prwebxml115275.php

PR Web (English) AmbosMedios (Español WunZhang (Traditional Chinese Home ... Search Archives June 2, 2004 CUSTOM NEWS FEED FOR JOURNALISTS MEMBER LOGIN (SUBMIT YOUR PRESS RELEASE) Customize your free daily PRWEB news feed. Register Here to Send Your Press Release ... All Press Releases for April 1, 2004 Respiratory Syncytial Virus (RSV) is the leading cause of viral death and respiratory tract infection (RTI) in children Research and Markets have announced the addition of the ‘Respiratory Syncytial Virus: Can Antivirals Make the Grade?’ report to their offering. (PRWEB) April 1, 2004 Respiratory Syncytial Virus (RSV) is the leading cause of viral death and respiratory tract infection (RTI) in children, and furthermore is a significant cause of morbidity in the elderly population. At present there is no effective vaccine or treatment against RSV infection, thereby constituting a considerable unmet medical need. Scope Overview of the etiology and epidemiology of RSV infection, discussing the scale and seriousness of this disease

76. Respiratory Syncytial Virus respiratory syncytial virus. Author Timothy Paustian, Posted 9/11/00; 20606 PM. Topic respiratory syncytial virus. Msg 45 (top msg in thread). http://www.bact.wisc.edu:8080/ScienceEd/discuss/msgReader$45

Science Education Science articles that you can understand Respiratory Syncytial Virus Author: Timothy Paustian Posted: 9/11/00; 2:06:06 PM Topic: Respiratory Syncytial Virus Msg #: (top msg in thread) Prev/Next: Reads: by Lindsey Monk Sunday, August 6, 2000 Respiratory Syncytial Virus (RSV) is one of the most common viruses, yet most people who have been affected by the virus never realize they are ill. However, this particular virus can cause severe lower respiratory illnesses such as bronchiolitis and pneumonia in infants, young children and the elderly. This virus can also have serious physiological effects on distinct groups our population, especially children who were born premature or who have immunodeficiency's, chronic lung conditions or congenital heart disease. This particular virus is very dangerous to young children because of their undeveloped immune system. However, it is known that two types of RSV, Type A and Type B, exist. Type B causes a mild upper respiratory infection that affects almost everybody and Type A is a severe lower respiratory tract infection that mainly affects infants, the elderly and those with a compromised immune system. Pathophysiologically, RSV attacks the bronchoalveolar epithelium, causing epithelial cell necrosis and an inflammatory response with a peri-bronchiolar infiltrate of lymphocytes, plasma cells and macrophages (Miller et al.,1999). The feeble or those with weak or compromised immunes systems are susceptible to the most severe form of RSV. Infants and children are at high risk for lower respiratory tract infections caused by the Type A virus. According to Miller et al. (1999), RSV is responsible for 45% to 75% of all cases of bronchiolities and pneumonia in infants and young children. During a child's first RSV infection, between 25% and 40% of infants and young children have signs or symptoms of bronchiolitis or pneumonia (National Center for Infectious Disease). RSV also tends to occur between six-weeks and two years of life. The severe Type A virus tends to occur in very young children who have a history of prematurity, congenital heart disease, chronic lung conditions or immunodeficiency. Other factors such as crowded unsanitary living conditions associated with low economic status, and exposure to cigarette smoke can increase the risk of being infected with RSV at a young age.

77. Respiratory Syncytial Virus respiratory syncytial virus. Previous topic Next topic respiratory syncytial virus, topic started 9/11/00; 20606 PM last post 9/11/00; 20606 PM. http://www.bact.wisc.edu:8080/ScienceEd/discuss/msgReader$45?mode=topic

78. Nat'l Academies Press, Vaccines For The 21st Century: (2000), Appendix 20: Respi Reducing the Morbidity of Lower Respiratory Tract Infections Caused by respiratory syncytial virus .Still No Answer . respiratory syncytial virus. http://books.nap.edu/openbook/0309056462/html/279.html

Read more than 3,000 books online FREE! More than 900 PDFs now available for sale HOME ABOUT NAP CONTACT NAP HELP ... ORDERING INFO Items in cart [0] TRY OUR SPECIAL DISCOVERY ENGINE Questions? Call 800-624-6242 Vaccines for the 21st Century: A Tool for Decisionmaking Institute of Medicine ( IOM CHAPTER SELECTOR: Openbook Linked Table of Contents Front Matter, pp. i-viii Contents, pp. ix-xii Executive Summary, pp. 1-10 Introduction, pp. 11-16 Progress in Vaccine Development, pp. 17-38 Considerations of Candidate Vaccines, pp. 39-52 Overview of Analytic Approach and Results, pp. 53-92 Review of the Analytical Model, pp. 93-108 Ethical Considerations and Caveats, pp. 109-122 Observations, pp. 123-132 References, pp. 133-142 Appendix 1: Borrelia burgdorferi , pp. 143-148 Appendix 2: Chlamydia, pp. 149-158 Appendix 3: Coccidioides Immitis , pp. 159-164 Appendix 4: Cytomegalovirus, pp. 165-172 Appendix 5: Enterotoxigenic E. coli , pp. 173-176 Appendix 6: Epstein-Barr Virus, pp. 177-180 Appendix 7: Helicobacter pylori , pp. 181-188

79. Pharmaceutical Research And Manufacturers Of America respiratory syncytial virus (RSV). Complete a new search There are no medicines for respiratory syncytial virus (RSV) listed in our database at this time. http://www.phrma.org/newmedicines/newmedsdb/drugs.cfm?indicationcode=Respiratory

80. Pediatric Pharmacotherapy respiratory syncytial virus (RSV) is one of the most common viral pathogens known to man. Nearly all children have been infected by the age of two years. http://www.people.virginia.edu/~smb4v/pedpharm/v3n10.htm

Pediatric Pharmacotherapy A Monthly Review for Health Care Professionals of the Children's Medical Center Volume 3, Number 10, September 1997 Prevention and Treatment of Respiratory Syncitial Virus - the search for a Cost-Effective Strategy Marcia L. Buck, Pharm.D. Introduction Ribaviran RSVIG Cost of Therapy ... References Pharmacology Literature Reviews Meropenem review Phenobarbital and peritoneal dialysis Safety issues with methylphenidate Formulary Update Respiratory syncytial virus (RSV) is one of the most common viral pathogens known to man. Nearly all children have been infected by the age of two years. Infection with RSV typically results in symptoms associated with a common cold. However, RSV may be a significant cause of morbidity and mortality in infants with underlying respiratory or cardiovascular disease, premature infants, immunocompromised patients, and the elderly. There are more than 90,000 annual hospitalizations in children for RSV lower respiratory tract infection. Two therapies for RSV are available in the United States. Ribavirin (Virazole ; ICN Pharmaceuticals) was approved in 1986 as a treatment for patients with RSV. Respiratory syncytial virus immune globulin (RespiGam

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 96    Back | 1  | 2  | 3  | 4  | 5  | Next 20